HOVLX | VIVIX | HOVLX / VIVIX | |
Total Expense Ratio | 0.62 | 0.04 | 1,550% |
Annual Report Gross Expense Ratio | 0.62 | 0.04 | 1,550% |
Fund Existence | 35 years | 27 years | - |
Gain YTD | 2.116 | 1.255 | 169% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 500 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 996M | 189B | 1% |
Annual Yield % from dividends | 1.17 | 2.29 | 51% |
Returns for 1 year | -1.61 | 6.80 | -24% |
Returns for 3 years | 5.34 | 18.51 | 29% |
Returns for 5 years | 15.05 | 58.67 | 26% |
Returns for 10 years | 18.58 | 102.87 | 18% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BBC | 20.53 | 0.78 | +3.92% |
Virtus LifeSci Biotech Clinical Trls ETF | |||
KBWY | 15.74 | 0.22 | +1.42% |
Invesco KBW Premium Yield Eq REIT ETF | |||
FITE | 72.49 | 0.82 | +1.14% |
SPDR® S&P Kensho Future Security ETF | |||
SPHD | 47.38 | 0.34 | +0.72% |
Invesco S&P 500® High Div Low Vol ETF | |||
FLTW | 49.40 | 0.34 | +0.68% |
Franklin FTSE Taiwan ETF |